Comparative genomics of Brucella species reveals key determinants of secondary metabolism, antimicrobial resistance, and virulence

布鲁氏菌属的比较基因组学揭示了次级代谢、抗菌素耐药性和毒力的关键决定因素

阅读:2

Abstract

The genomes of 40 Brucella strains were retrieved from the NCBI database to investigate Brucellosis at the genomic level, focusing on secondary metabolites, resistance genes, and virulence factors. Genome analysis software, secondary metabolite mining tools, and relevant gene databases were employed for detailed analysis. The genome sizes of these strains range from 4.88 to 6.00 MB, with G+C content between 53.5 and 60.5%. Phylogenetic analysis classified the strains into three distinct clades: Brucella anthropi CCUG 34461, Brucella sp. NBRC 13694, and Brucella anthropi MAG47. Pan-genome analysis revealed 21,800 gene families, 198 core genes, and 10,371 unique genes, indicating an open pan-genome. The secondary metabolite mining software identified 18 categories and 350 gene clusters, predicting a total of 298 secondary metabolites, primarily arylpolyene, acyl-amino acids, betalactone, terpene, hydrogen cyanide, and NAGGN. Genome sequences were uploaded in FASTA format to the CARD resistance gene database, identifying seven resistance genes: rpsE, rpsL, rosA, golS, fabG, fabI, and uL3. B. anthropi SBA01 and B. media Q1108 were found to harbor the highest number of drug resistance genes. Likewise, the sequences were compared to the VFDB virulence gene database, revealing eight virulence genes: lpxC, acpXL, fliY, bspJ, lpxA, fliI, fliQ, and bvrR. The B. cytisi IPA7.2 strain exhibited the highest number of virulence genes, with lpxC and acpXL potentially being unique to Brucella compared to other species. This study provides comprehensive genomic data, elucidating the relationship between the pan-genome, core genome, and genome size, while predicting the types of secondary metabolites, resistance, and virulence genes. These findings provide a basis for comprehensively understanding Brucella and lay a solid foundation for its prevention and treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。